Today: 21 May 2026
NASA calls ISS briefing as Crew-11 medical issue raises early return option
8 January 2026
2 mins read

NASA calls ISS briefing as Crew-11 medical issue raises early return option

WASHINGTON, January 8, 2026, 16:54 EST

  • NASA is weighing a rare early return for its SpaceX Crew-11 team after an astronaut medical issue.
  • A planned spacewalk was called off, with the affected crew member described as stable.
  • NASA is due to brief media from Washington later on Thursday.

NASA is considering ending the Crew-11 mission early and bringing its astronauts home from the International Space Station after an unspecified medical issue hit one crew member, prompting the cancellation of a planned spacewalk, the agency said. NASA described the astronaut as stable and did not identify the person, citing medical privacy.

NASA will host a live news conference at 5 p.m. EST on Thursday from its Washington headquarters to discuss the space station and its crew. The participants listed include NASA Administrator Jared Isaacman, associate administrator Amit Kshatriya and Dr. James Polk, NASA’s chief health and medical officer.

The timing matters because the station calendar is tight and any early undocking can ripple quickly. Spaceflight Now reported the next U.S. crew rotation flight, SpaceX’s Crew-12, is currently slated for no earlier than Feb. 15, and it is unclear how much flexibility exists to move it up. “It is on orbit, waiting to be installed. We just have to go out there and install it,” Bill Spetch, an operations integration manager for NASA’s ISS Program, said, referring to hardware tied to upcoming power work. Spaceflight Now

NASA first disclosed the situation on Wednesday, saying it was postponing the Jan. 8 spacewalk after a “medical concern” arose that afternoon aboard the orbiting complex. The agency said it would share additional details, including a new date for the spacewalk, later. NASA

In an overnight email update cited by Space.com, NASA said it was “actively evaluating all options, including the possibility of an earlier end to Crew-11’s mission,” and promised further updates within 24 hours. Crew-11 includes NASA astronauts Zena Cardman and Mike Fincke, Japan’s Kimiya Yui and Russian cosmonaut Oleg Platonov, Space.com reported. Space

The canceled outing was an extravehicular activity, or EVA — a spacewalk — that had been expected to run about 6.5 hours starting around 8 a.m. ET, with Fincke and Cardman scheduled to work outside the station, Space.com reported. The job list included preparations for installing an International Space Station Roll-Out Solar Array (iROSA), a fold-out panel designed to add power and support the station’s eventual controlled deorbit.

Crew-11 flew to the station on a SpaceX Crew Dragon capsule under NASA’s commercial crew program, which has become the main ride for U.S. astronauts to and from orbit. The station’s seven-person crew also includes members launched on Russia’s Soyuz spacecraft, underscoring the mixed-vehicle setup NASA and its partners use to keep the outpost staffed.

But the agency has not said what the medical problem is, or how long it might limit work, leaving open a wide range of outcomes from a quick return to a short pause in station activities. A decision to end the mission early could squeeze maintenance and spacewalk timelines, while a decision to stay put would depend on how the crew member responds in the days ahead.

NASA is expected to provide more detail at the Washington briefing later Thursday, and has said it will update again within 24 hours.

Stock Market Today

  • Sensex nudges up as oil prices drop and rupee strengthens
    May 21, 2026, 3:46 AM EDT. Indian shares edged higher on Thursday, with the BSE Sensex up 0.20% and the Nifty 50 gaining 0.30%. The rise followed a decline in Brent crude oil prices, which dipped 5.6% near $106 a barrel, and a rebound in the rupee supported by Reserve Bank of India dollar sales. Despite early gains fading, investor sentiment improved amid easing inflation pressures and stabilizing currency. Key earnings influenced moves, with Apollo Hospitals posting a 36% profit increase and Lenskart Solutions reporting 46% revenue growth. Caution persisted over Ola Electric due to a 5% revenue decline. Market momentum depends on crude oil trends and rupee stability as investors balance earnings strength against macroeconomic challenges like high U.S. bond yields.

Latest articles

Fed Officials Float Rate Hikes Again as Cut Hopes Wobble

Fed Officials Float Rate Hikes Again as Cut Hopes Wobble

21 May 2026
Federal Reserve minutes released Wednesday showed most officials see possible rate hikes if inflation remains above 2%. Markets and economists have pushed back expectations for rate cuts, with some now anticipating increases. The Fed’s benchmark rate held at 3.50% to 3.75% in April. The next FOMC meeting is set for June 16-17.
Treasury yields close in on 2007 highs, Wall Street takes note

Treasury yields close in on 2007 highs, Wall Street takes note

21 May 2026
The 30-year U.S. Treasury yield reached 5.128% early Thursday, near its highest level since 2007, with the 10-year at 4.593%. Treasury data showed the 30-year par yield at 5.11% Wednesday, down from 5.18% Tuesday. The average 30-year fixed U.S. mortgage rate rose to 6.56%, the highest in seven weeks, as mortgage applications fell 2.3%. Fed minutes showed most policymakers see more tightening if inflation stays above 2%.
Asia Chips Rally Lifts Nvidia, Samsung Shares

Asia Chips Rally Lifts Nvidia, Samsung Shares

21 May 2026
Asian stocks jumped Thursday, led by chipmakers after Nvidia forecast stronger revenue and Samsung Electronics reached a deal to avert a strike. MSCI’s Asia-Pacific index outside Japan rose 2.6%, with South Korea’s KOSPI up over 7% and Samsung shares nearly 8% higher. SK Hynix surged 11.3%. Japan’s exports climbed 14.8% in April, but its services PMI fell to 50.0, ending more than a year of growth.
Sandisk (SNDK) stock drops after CES-fueled surge cools, with earnings next
Previous Story

Sandisk (SNDK) stock drops after CES-fueled surge cools, with earnings next

AbbVie stock slides on $1.3 billion charge and outlook cut as deal chatter swirls
Next Story

AbbVie stock slides on $1.3 billion charge and outlook cut as deal chatter swirls

Go toTop